Haemonetics Corporation
HAE
$53.12
-$0.62-1.15%
NYSE
| 06/28/2025 | 03/29/2025 | 12/28/2024 | 09/28/2024 | 06/29/2024 | |
|---|---|---|---|---|---|
| Net Income | 42.17% | 42.64% | 2.76% | -3.48% | -15.87% |
| Total Depreciation and Amortization | 14.39% | 22.88% | 25.30% | 18.78% | 10.82% |
| Total Amortization of Deferred Charges | -22.09% | -22.09% | -8.24% | -15.33% | -11.09% |
| Total Other Non-Cash Items | 21.13% | -107.63% | -80.42% | -73.31% | -51.57% |
| Change in Net Operating Assets | 26.59% | -31.67% | -59.63% | -862.54% | -393.66% |
| Cash from Operations | 67.51% | -0.01% | -34.48% | -67.61% | -45.94% |
| Capital Expenditure | 2.79% | 8.02% | 39.78% | 66.01% | 54.13% |
| Sale of Property, Plant, and Equipment | -85.36% | 1,184.70% | 542.27% | 528.12% | 1,339.81% |
| Cash Acquisitions | 99.55% | 38.12% | 38.12% | -- | -- |
| Divestitures | 2,786.07% | 2,786.07% | -- | -- | 76.47% |
| Other Investing Activities | -58.35% | 2.87% | -10.00% | -91.34% | -47.43% |
| Cash from Investing | 87.52% | 49.78% | 41.04% | -368.44% | -342.63% |
| Total Debt Issued | -100.00% | 763.64% | 763.64% | -- | 221.21% |
| Total Debt Repaid | 112.69% | -595.76% | -5,277.38% | -864.36% | -95.33% |
| Issuance of Common Stock | -3.07% | 15.51% | 14.20% | 19.43% | 2.40% |
| Repurchase of Common Stock | -1,527.15% | -3,897.33% | -1,348.48% | -1,352.19% | 81.50% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -280.22% | -12,002.39% | -13,418.77% | -12,437.91% | -1,055.86% |
| Cash from Financing | -161.03% | 185.18% | 96.66% | 616.17% | 580.16% |
| Foreign Exchange rate Adjustments | 286.07% | 78.49% | -27,881.82% | 101.90% | -171.57% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -187.77% | 221.10% | 522.56% | -147.10% | -17.04% |